Table 1.

Gene Expression Assays

Company	Assay Name	Indication	Result
Genomic Health Inc. (Redwood City, CA)	Oncotype DX® Prostate Cancer assay	Positive prostate biopsy	Genomic prostate score from 0 to 100 Likelihood of freedom from higher Gleason scorea and/or non-organ-confined disease
GenomeDX Biosciences (San Diego, CA)	Decipher®	Post radical prostatectomy	Risk of metastasis at 5 years post prostatectomy and 3 years post PSA recurrence
Myriad Genetics (Salt Lake city, UT)	Prolaris®	Positive prostate biopsy or Post radical prostatectomy	10-year PCSM risk or 10-year BCR risk

BCR, biochemical recurrence; PCSM, prostate cancer-specific mortality; PSA, prostate-specific antigen.

^aHigh Gleason score defined as Gleason dominant pattern 4 or any Gleason pattern 5.